Evidence map›Paper›PMID 36794719›Full record

ArticleNucleic acids research2023

Structure, substrate binding and activity of a unique AAA+ protein: the BrxL phage restriction factor.

Betty W Shen, Lindsey A Doyle, Rachel Werther, Abigail A Westburg, Daniel P Bies, Stephanie I Walter, Yvette A Luyten, Richard D Morgan, Barry L Stoddard, Brett K Kaiser

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Modified DNA substrate selectivity by GmrSD-family Type IV restriction enzyme BrxU.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Diversity and phage sensitivity to phages of porcine enterotoxigenicApplied and environmental microbiology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Betty W ShenDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. North, Seattle, WA 98109, USA.
Lindsey A DoyleDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. North, Seattle, WA 98109, USA.ORCID 0000-0002-0008-473X
Rachel WertherDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. North, Seattle, WA 98109, USA.
Abigail A WestburgDepartment of Biology, Seattle University, 901 12th Avenue, Seattle, WA 98122, USA.
Daniel P BiesDepartment of Biology, Seattle University, 901 12th Avenue, Seattle, WA 98122, USA.
Stephanie I WalterDepartment of Biology, Seattle University, 901 12th Avenue, Seattle, WA 98122, USA.
Yvette A LuytenNew England Biolabs, 240 County Road, Ipswich, MA 01938, USA.
Richard D MorganNew England Biolabs, 240 County Road, Ipswich, MA 01938, USA.
Barry L StoddardDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. North, Seattle, WA 98109, USA.ORCID 0000-0001-5174-7858
Brett K KaiserDepartment of Biology, Seattle University, 901 12th Avenue, Seattle, WA 98122, USA.
North Seattle College · USSeattle University · USNew England Biolabs (United States) · US

Funding

User Training and OutreachP30GM124169 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI PAUL David ADAMS, Gregory L Hura · 2017 to 2026
$28.6M
MegaTALS: hyperspecific reagents for targeted gene modification and correctionR01GM105691 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STODDARD, BARRY L. · 2014 to 2022
$2.7M
Pilatus 6mS10OD021832 · OD · UNIVERSITY OF CALIFORNIA BERKELEY · PI ADAMS, PAUL DAVID · 2016 to 2016
$980k
Characterization of the Bacterial BREX Phage Restriction System - Administrative SupplementR15GM140375 · NIGMS · SEATTLE UNIVERSITY · PI Brett Kian Kaiser · 2021 to 2026
$919k
A Fast Pixel-Array Pilatus 2M Detector for Automated Macromolecular Crystallography Data CollectionS10OD026941 · OD · UNIVERSITY OF CALIFORNIA BERKELEY · PI ADAMS, PAUL DAVID · 2019 to 2019
$563k
Howard Hughes Medical InstituteNIGMS NIH HHS P30 GM124169NIGMS NIH HHS R01 GM105691NIGMS NIH HHS R15 GM140375NIH HHS S10 OD021832NIH HHS S10 OD026941
6 · The paper itself

Abstract

Bacteriophage exclusion ('BREX') systems are multi-protein complexes encoded by a variety of bacteria and archaea that restrict phage by an unknown mechanism. One BREX factor, termed BrxL, has been noted to display sequence similarity to various AAA+ protein factors including Lon protease. In this study we describe multiple CryoEM structures of BrxL that demonstrate it to be a chambered, ATP-dependent DNA binding protein. The largest BrxL assemblage corresponds to a dimer of heptamers in the absence of bound DNA, versus a dimer of hexamers when DNA is bound in its central pore. The protein displays DNA-dependent ATPase activity, and ATP binding promotes assembly of the complex on DNA. Point mutations within several regions of the protein-DNA complex alter one or more in vitro behaviors and activities, including ATPase activity and ATP-dependent association with DNA. However, only the disruption of the ATPase active site fully eliminates phage restriction, indicating that other mutations can still complement BrxL function within the context of an otherwise intact BREX system. BrxL displays significant structural homology to MCM subunits (the replicative helicase in archaea and eukaryotes), implying that it and other BREX factors may collaborate to disrupt initiation of phage DNA replication.

Indexed as

AcinetobacterProtease LaAdenosine TriphosphatasesAdenosine TriphosphateArchaeaBacteriophagesDNADNA HelicasesProtein BindingAdenosine TriphosphatasesAdenosine TriphosphateDNADNA HelicasesProtease La

Identifiers

PMID36794719
PMCPMC10164562
OpenAlexW4320932988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.